Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

Tandon P, Garcia-Tsao G.

Liver Int. 2009 Apr;29(4):502-10. doi: 10.1111/j.1478-3231.2008.01957.x. Epub 2008 Dec 24. Review.

PMID:
19141028
2.

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.

Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.

Cancer. 2001 Jul 1;92(1):126-35.

PMID:
11443618
3.

Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.

Ollivier I, Dauvois B, Guittet L, Boutreux S, Dupont B, Launoy G, Dao T.

Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):288-96. doi: 10.1016/j.gcb.2010.01.005. Epub 2010 Feb 26.

PMID:
20189339
4.

Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.

Dhooge M, Coriat R, Mir O, Perkins G, Brezault C, Boudou-Rouquette P, Goldwasser F, Chaussade S.

Oncology. 2013;84(1):32-8. doi: 10.1159/000342763. Epub 2012 Oct 16.

PMID:
23076239
5.

[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].

Witjes CD, de Man RA, Eskens FA, Dwarkasing RS, Zondervan PE, Verhoef C, Ijzermans JN.

Ned Tijdschr Geneeskd. 2010;154:A1747. Dutch.

PMID:
20719013
6.

Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.

Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM.

Liver Int. 2012 Oct;32(9):1407-14. doi: 10.1111/j.1478-3231.2012.02830.x. Epub 2012 Jun 11.

PMID:
22679906
7.

Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.

Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S.

Surgery. 2007 Nov;142(5):685-94.

PMID:
17981188
8.

Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience.

Lee SS, Shin HS, Kim HJ, Lee SJ, Lee HS, Hyun KH, Kim YH, Kwon BW, Han JH, Choi H, Kim BH, Lee JH, Kang HY, Shin HD, Song IH.

Korean J Hepatol. 2012 Mar;18(1):48-55. doi: 10.3350/kjhep.2012.18.1.48. Epub 2012 Mar 22.

PMID:
22511903
9.

Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.

Hata M, Tokuuye K, Sugahara S, Fukumitsu N, Hashimoto T, Ohnishi K, Nemoto K, Ohara K, Matsuzaki Y, Akine Y.

Strahlenther Onkol. 2006 Dec;182(12):713-20.

PMID:
17149578
10.

Clinical staging of hepatocellular carcinoma.

Meier V, Ramadori G.

Dig Dis. 2009;27(2):131-41. doi: 10.1159/000218345. Epub 2009 Jun 22. Review.

PMID:
19546551
11.

Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.

Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U.

Jpn J Clin Oncol. 2008 Oct;38(10):683-8. doi: 10.1093/jjco/hyn082. Epub 2008 Aug 27.

PMID:
18753360
12.

[Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].

Lim TY, Cheong JY, Cho SW, Sim SJ, Kim JS, Choi SJ, Choi JW, Kwon HC, Lee KM, Kim JK, Won JH, Yoo BM, Lee KJ, Hahm KB, Kim JH.

Korean J Hepatol. 2006 Mar;12(1):65-73. Korean.

PMID:
16565607
13.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
14.

The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L.

PLoS One. 2012;7(12):e50919. doi: 10.1371/journal.pone.0050919. Epub 2012 Dec 7.

PMID:
23236406
15.

Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.

Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S, Iacono C.

J Gastrointest Surg. 2007 Feb;11(2):143-9.

PMID:
17390163
16.

Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.

Kikuchi LO, Paranaguá-Vezozzo DC, Chagas AL, Mello ES, Alves VA, Farias AQ, Pietrobon R, Carrilho FJ.

J Clin Gastroenterol. 2009 Feb;43(2):191-5. doi: 10.1097/MCG.0b013e31817ff199.

PMID:
19142170
17.

[Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].

Liang BY, Huang ZY, Liu YA, Hou P, Ji GB, Chen XP.

Zhonghua Wai Ke Za Zhi. 2012 Oct;50(10):865-9. Chinese.

PMID:
23302452
18.

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

Stuart KE, Anand AJ, Jenkins RL.

Cancer. 1996 Jun 1;77(11):2217-22.

PMID:
8635087
19.

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.

Ozenne V, Paradis V, Pernot S, Castelnau C, Vullierme MP, Bouattour M, Valla D, Farges O, Degos F.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1106-10. doi: 10.1097/MEG.0b013e3283386053.

PMID:
20300004
20.

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, Varotti G, Cetta F, Cavallari A.

Ann Surg. 2003 Apr;237(4):536-43.

PMID:
12677151
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk